UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Access to the comments Comments
By Reuters
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine   -   Copyright  Thomson Reuters 2021   -  

<div> <p> – The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (<span class="caps">GBS</span>), as a very rare side effect of the AstraZeneca <span class="caps">COVID</span>-19 vaccine, updates on the agency’s website showed on Thursday.</p> <p>Medicines and Healthcare products Regulatory Agency’s (<span class="caps">MHRA</span>) decision comes after the European medicines agency added <span class="caps">GBS</span> as a possible side-effect last month. </p> <p/> </div>